85
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Haemo-Adhaesione: A New Measure of Adherence for Adolescent and Adult Patients with Haemophilia

ORCID Icon, ORCID Icon, , , &
Pages 455-465 | Published online: 03 Mar 2020
 

Abstract

Purpose

To build a multidimensional questionnaire of adherence for a patient with hemophilia that includes not only clinical but also psychosocial aspects.

Patients and Methods

One hundred and forty-six patients with haemophilia (A and B) were recruited from several Hemophilia Treatment Centers for this study. The recruitment was performed through a personal interview (20–25 mins for each patient). A literature review was carried out (different databases). In the first version (136 items), all items were subjected to an external judgment (experts in hemophilia) and also presented and discussed with a group of patients. It was made a study of content validity and homogeneity index and reliability coefficients of score were calculated with an alpha coefficient. Empirical validation was made with Pearson correlation.

Results

The Haemo-Adhaesione scale was composed of 5 dimensions and 10 questions about basic haemophilia concepts. It was shown to be valid and reliable to assess adherence in the Spanish population. Its internal consistency was good in all dimensions. The Rasch model was used to confirm the multidimensional structure of the scale. Significant and negative correlations were observed with the VERITAS-Pro and VERITAS-PRN scale in all dimensions, and in the total score.

Conclusions

The Haemo-Adhaesione scale is a good measure of adherence for PWH. Its multidimensional structure favors the inclusion of the objective and subjective aspects implicit in its definition, as well as its dynamic nature. Patients with greater adherence are those who have more awareness of their disease, and as a result, they are more compliant with prescription and their self-care. It also discriminates between patients who follow one treatment or another.

Acknowledgment

The authors are grateful to the Hemophilia Associations´ patients in Spain for their help in recruiting the sample and to the professional of Haemophilia Treatment Centers who have collaborated as external judges.

Author Contributions

All authors contributed to data analysis, drafting or revising the article, gave final approval of the version to be published, and agree to be accountable for all aspects of the work.

Disclosure

The authors report no conflicts of interest in this work. The authors state that this work has received Investigator-Initiated Research grant from Baxalta US Inc., now part of Takeda group of companies, Bannockburn, IL.